|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||
Index of Online Supplemental Material for
J. Cell Biol. 10.1083/jcb.200407113
Damm et al.
• Figure S1 Cav-1KO and HuH7 cells do not contain cav-1.
• Figure S2 Internalization and infection of SV40 occurs independently of Eps15 and Dynamin II.
• Figure S3 Latrunculin A treatment does not inhibit infection with SV40 in HuH7 cells but in cav-1KO cells.
• Figure S4 SV40 containing endosomes are pH neutral, disconnected from the plasma membrane, and different to vesicles of the classical endosomal pathway.
• Figure S5 18 h after internalization, SV40 ends up in the smooth ER.
• Video 1 (3.5 MB) AF594-SV40 enters cytosolic organelles in cav-1KO cells.
• Video 2 (504 K) AF594-SV40 enters cytosolic organelles in cav-1KO cells (detail).
• Video 3 (2.8 MB) SV40-containing vesicular and tubular carriers interact with microtubules.
• Video 4 (504 K) Virus-induced activation of cytosolic organelles.
• Video 5 (5.5 MB) SV40 internalization in cav-1KO cells treated with nocodazole.
• Video 6 (8.4 MB) SV40 entry into cav-1KO cells transfected with cav-1.
• Video 7 (5.8 MB) Internalized SV40 enters caveosomes in cav-1KO cells expressing caveolin-1.
• Video 8 (4.9 MB) Caveolin-negative SV40 particles merge with preexisting caveosomes in cav-1WT cells.
| ||||||||||||||||||||||||||
|
|
